Kursprognose für Corbus Pharmaceuticals Holdings Inc (CRBP)CRBPCorbus Pharmaceuticals Holdings Inc

Alphio's CRBP stock price prediction model matches the current Corbus Pharmaceuticals Holdings Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.08 (+0.17%). The 1-week path is $3.07 (-0.14%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Corbus Pharmaceuticals is not a good buy right now. The current price is $3.915, which is significantly lower than the 52-week high of $12.88, indicating a downtrend. The RSI is at 21.889, suggesting that the stock is oversold, but this could also indicate continued weakness. Furthermore, the company has reported substantial losses, with a net income of -$35,037,000 in Q2 2026, and a forward P/E ratio of 0, indicating no earnings expected in the near term. The main risk is the high volatility, as indicated by an implied volatility of 327.95% and a historical volatility of 55.29%.

Corbus Pharmaceuticals Holdings Inc (CRBP) last closed at $3.0699999, gaining +7.34%. These facts feed the 1-day and 1-week CRBP price prediction above.